Register Now

FDA fast track status granted to iECURE neonatal OTC deficiency treatment

ECUR-506 is being evaluated in the first-in-human Phase I/II OTC-HOPE study.

Sobi's Aspaveli obtains indication extension approval in Europe

The approval for Aspaveli's extended indication is based on data from the APL2-308 (PRINCE) study.

Biotechs must prioritise ethics to deter GenAI “bad actors”

At the London Biotechnology Show, Microsoft’s senior director of life sciences discussed the ethical use of GenAI.

Zenas raises $200m to advance autoimmune antibody therapy

Zenas signed a licensing deal for Asia-Pacific territories for the bispecific antibody therapy, obexelimab, with Bristol Myers Squibb in September 2023.

Regenex Bio eyes FDA meeting to confirm pivotal DMD trial

Regenex Bio will sit down with the FDA in Q3 2024 to finalise the Phase III trial design.

Acepodia reports preliminary results from ACE1831 Phase I trial

The preliminary data indicates potential benefits for non-Hodgkin's lymphoma patients.

Teva and Medincell report positive data for TEV-‘749 in schizophrenia trial

TEV-‘749 has met primary endpoint in Phase III trial, showing significant symptom reduction in schizophrenia patients.

15th Annual Outsourcing in Clinical Trials East Coast 2024

The upcoming Outsourcing in Clinical Trials Europe 2024 conference will explore advancements in the clinical trial industry.